SCHEMBL6560975

SCHEMBL6560975

CN(C)S(=O)(=O)N(C)C1CC(C)(C)Oc2ccc(F)cc21

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 4/20 0.47
KCNQ1 P51787 4/20 0.47
TRPV1 Q8NER1 14/20 0.41
CYP3A4 P08684 1/20 0.37
CFTR P13569 1/20 0.35
AKR1B1 P15121 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559271 0.86 KCNE1 (0.61) KCNE1KCNQ1TRPV1CYP3A4AKR1B1
SCHEMBL6559550 0.83 MEN1 (0.37) KCNE1KCNQ1AKR1B1
SCHEMBL6559957 0.82 KCNE1 (0.50) KCNE1KCNQ1CYP3A4
SCHEMBL6558778 0.81 HTR1A (0.36) KCNE1KCNQ1
SCHEMBL6559569 0.79 RAB9A (0.37)
SCHEMBL6559266 0.79 KCNE1 (0.52) KCNE1KCNQ1TRPV1CYP3A4AKR1B1
SCHEMBL6560815 0.77 TRPV1 (0.48) KCNE1KCNQ1TRPV1CYP3A4CFTR
SCHEMBL6558722 0.75 KCNE1 (0.48) KCNE1KCNQ1TRPV1CYP3A4AKR1B1
SCHEMBL8477514 0.75 KCNE1 (0.50) KCNE1KCNQ1TRPV1CYP3A4CFTR
SCHEMBL7468526 0.74 KCNE1 (0.49) KCNE1KCNQ1TRPV1CYP3A4AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed